Drug Shortage Report for NAT-BOSENTAN
| Report ID | 243351 |
| Drug Identification Number | 02467984 |
| Brand name | NAT-BOSENTAN |
| Common or Proper name | Bosentan |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BOSENTAN |
| Strength(s) | 62.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 56 BLS |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-18 |
| Estimated end date | 2025-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-01-02 | French | Compare |
| v4 | 2025-01-02 | English | Compare |
| v3 | 2024-11-19 | English | Compare |
| v2 | 2024-11-18 | French | Compare |
| v1 | 2024-11-18 | English | Compare |
Showing 1 to 5 of 5